SPAGO — Spago Nanomedical AB (publ) Cashflow Statement
0.000.00%
Last trade - 00:00- SEK74.61m
- SEK42.36m
- SEK1.20m
Annual cashflow statement for Spago Nanomedical AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | SAS | SAS | SAS | SAS | SAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20.2 | -19 | -39.2 | -39.5 | -43.1 |
| Non-Cash Items | 0.357 | 0.362 | 0.376 | 0.356 | 0.472 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.44 | -0.166 | 3.25 | 0.922 | -2.31 |
| Change in Accounts Receivable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.3 | -18.8 | -35.6 | -38.2 | -44.9 |
| Capital Expenditures | — | — | — | — | -0.153 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -18.2 | -6.38 | -4.63 | -3.83 | -0.353 |
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -18.2 | -6.38 | -4.63 | -3.83 | -0.506 |
| Financing Cash Flow Items | 0.001 | — | 64.2 | 51.7 | 28.5 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 35.2 | 41.4 | 64.2 | 51.7 | 28.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -4.32 | 16.3 | 24 | 9.64 | -16.9 |